BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 6611543)

  • 1. Autologous rosette-forming capacity of T-lymphocytes in Hodgkin's disease.
    Bodolay E; Berényi E; Sonkoly I; Szegedi G
    Acta Med Hung; 1984; 41(2-3):113-9. PubMed ID: 6611543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM; Bigel P; Oberling F; Mayer S
    Sem Hop; 1978 Nov 8-15; 54(37-40):1155-8. PubMed ID: 217096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM; Bigel P; Oberling F; Mayer S
    Pathol Biol (Paris); 1978; 26(3-4):159-62. PubMed ID: 355984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subpopulations of human T lymphocytes in patients with Hodgkin's disease before and after treatment.
    Karande AA; Gulwani B; Advani SH; Gangal SG
    Neoplasma; 1982; 29(2):149-59. PubMed ID: 6981068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect.
    Engleman EG; Benike CJ; Hoppe RT; Kaplan HS; Berberich FR
    J Clin Invest; 1980 Jul; 66(1):149-58. PubMed ID: 6447164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in human lymphocyte subpopulation in Hodgkin's lymphoma.
    Rejthar A; Patera J; Rejtharová A; Hrdlicková N
    Neoplasma; 1976; 23(4):371-5. PubMed ID: 1087377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral lymphocyte count and suppopulations of T and B lymphocytes in benign and malignant diseases.
    Lee YT
    Surg Gynecol Obstet; 1977 Mar; 144(3):435-50. PubMed ID: 300179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitivity of Hodgkin's disease lymphocytes.
    Baral E; Blomgren H; Rotstein S
    J Clin Lab Immunol; 1981 Mar; 5(2):101-5. PubMed ID: 7218327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune status of untreated patients with Hodgkin's disease and prognosis.
    Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
    Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous rosette-forming T cells as the responding cells in human autologous mixed-lymphocyte reaction.
    Palacios R; Llorente L; Alarcón-Segovia D; Ruíz-Arguelles A; Díaz-Jouanen E
    J Clin Invest; 1980 Jun; 65(6):1527-30. PubMed ID: 6447710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levamisole in the treatment of Hodgkin's disease.
    Berényi E; Kávai M; Szabolcsi M; Szegedi G
    Acta Med Acad Sci Hung; 1979; 36(2):177-85. PubMed ID: 317549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.
    Hillinger SM; Herzig GP
    J Clin Invest; 1978 Jun; 61(6):1620-7. PubMed ID: 149140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin's disease in children: investigation of T and B lymphocytes.
    Ilyin NV; Kolygin BA; Letsky VB; Fedoreev GA; Zubzhitsky YN
    Neoplasma; 1978; 25(1):75-81. PubMed ID: 305545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
    Fuks Z; Strober S; Kaplan HS
    N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro stimulation of T-cell rosette formation by antiserum to thymus factor in Hodgkin's disease.
    Zółtowska A; Arendt M; Gan J
    Arch Immunol Ther Exp (Warsz); 1984; 32(1):51-7. PubMed ID: 6332594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proportions and absolute count of T- and B-lymphocytes in peripheral blood and their blastic transformation induced by mitogens in splenectomized and non-splenectomized patients with Hodgkin's disease].
    Pluzańska A
    Acta Haematol Pol; 1978; 9(1):37-44. PubMed ID: 307325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characterization of T lymphocyte defects in patients with Hodgkin's disease using enzyme chemical markers].
    Wendt C; Schön E; Gaede B; Franke A; Ansorge S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):851-7. PubMed ID: 1713892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Concentration of rosette-forming cells and functional activity of peripheral blood T-lymphocytes in patients with different stages of lymphogranulomatosis].
    Loseva MI; Fridliand DIu
    Ter Arkh; 1981; 53(9):68-71. PubMed ID: 6975503
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition or stimulation of immediate, spontaneous rosette formation at various SRBC:lymphocyte ratios.
    Skopińska E; Nowaczyk M; Zółtowska A; Wojtulewicz-Kurkus J; Wierzchowska E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):577-88. PubMed ID: 6970025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative study of T and B lymphocytes in Hodgkin's disease.
    Bensa JC; Micouin C; Schaerer R; Sotto JJ; Hollard D
    Biomedicine; 1977 Apr; 26(2):137-44. PubMed ID: 326312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.